Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Articles
Flagship Journal
5
Mins
11 Sep 2025
Anti-IL-23 Blocks Pathogenic T Cells
Psoriasis affects 60 million people globally. It is an inflammatory skin condition that can significantly impact quality of life…
Flagship Journal
6
Mins
11 Sep 2025
A Case of Retroperitoneal Leiomyosarcoma of the Inferior Vena Cava
Leiomyosarcoma (LMS) is a malignant neoplasm characterised by smooth muscle differentiation. It is the second most common sarcoma to…
Flagship Journal
6
Mins
11 Sep 2025
Nivolumab in Patients with Relapsed-Refractory Hodgkin Lymphoma
Up to a quarter of patients with classical Hodgkin’s lymphoma (HL) are resistant or have disease relapse after first-line chemotherapy…
Flagship Journal
8
Mins
11 Sep 2025
Atypical Postpartum Group A Streptococcal Sepsis with Toxic Shock: Case Report
Sepsis continues to be a significant contributor to maternal mortality, and is responsible for approximately 11% of maternal deaths…
Cardiology
3
Mins
10 Sep 2025
From Imaging to Advocacy: Interview with David E. Winchester
The technology that I use most frequently is coronary flow reserve combined with PET perfusion imaging and coronary artery calcium scoring…
Oncology
10 Sep 2025
Avelumab 1L Maintenance in aUC: Insights from 5000+ Real-World Patients
Urothelial carcinoma (UC), a prevalent cancer affecting the urinary tract, often progresses to an advanced, terminal…
Cardiology
2
Mins
8 Sep 2025
Leading Cardiology Forward: Interview with Christopher M. Kramer
I began research on cardiovascular magnetic resonance (CMR) with Reichek as one of my two main mentors, and the rest is history.
Oncology
14
Mins
5 Sep 2025
Sponsored Content: EV+P use in Comorbid Patients with u/mUC
This promotional material is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd…
Loading posts...
« Previous
1
2
3
4
…
282
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View